Single nucleotide polymorphism rs2229634 in the ITPR3 gene is associated with the risk of developing coronary artery aneurysm in children with Kawasaki disease

International Journal of Immunogenetics

Volumn 37, Issue 6, 2010, Pages 439-443

  Huang, Y C ^a,b   Lin, Y J ^a,b   Chang, J S ^a   Chen, S Y ^a,b   Wan, L ^a,b,c   Sheu, J C ^a,b,c   Lai, C H ^d   Lin, C W ^b   Liu, S P ^a,e   Chen, C P ^b,c,f,g   Tsai, F J ^a,c  

^a CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^b CHINA MEDICAL UNIVERSITY   (Taiwan)

^c ASIA UNIVERSITY   (Taiwan)

^d CHINA MEDICAL UNIVERSITY   (Taiwan)

^e CHINA MEDICAL UNIVERSITY   (Taiwan)

^f MACKAY MEMORIAL HOSPITAL   (Taiwan)

^g NATIONAL YANG MING UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; INOSITOL 1,4,5 TRISPHOSPHATE RECEPTOR; INOSITOL 1,4,5 TRISPHOSPHATE RECEPTOR 3; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; ARTICLE; CARDIOVASCULAR RISK; CHILD; CONTROLLED STUDY; CORONARY ARTERY ANEURYSM; FEMALE; GENE FREQUENCY; GENETIC VARIABILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; MUCOCUTANEOUS LYMPH NODE SYNDROME; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM;

ALLELES; ASIAN CONTINENTAL ANCESTRY GROUP; C-REACTIVE PROTEIN; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; CHROMOSOMES, HUMAN, PAIR 6; CORONARY ANEURYSM; GENE FREQUENCY; GENETIC MARKERS; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; INOSITOL 1,4,5-TRISPHOSPHATE RECEPTORS; MUCOCUTANEOUS LYMPH NODE SYNDROME; POLYMORPHISM, SINGLE NUCLEOTIDE; TAIWAN;

EID: 77958545372     PISSN: 17443121     EISSN: 1744313X     Source Type: Journal    
DOI: 10.1111/j.1744-313X.2010.00943.x     Document Type: Article

References (37)

1. Arjunan, K., Daniels, S.R., Meyer, R.A., Schwartz, D.C., Barron, H. & Kaplan, S. (1986) Coronary artery caliber in normal children and patients with Kawasaki disease but without aneurysms: an echocardiographic and angiographic study. Journal of the American College of Cardiology, 8, 1119.
2. Atkinson, M.A. & Eisenbarth, G.S. (2001) Type 1 diabetes: new perspectives on disease pathogenesis and treatment. Lancet, 358, 221.
3. Blackshaw, S., Sawa, A., Sharp, A.H., Ross, C.A., Snyder, S.H. & Khan, A.A. (2000) Type 3 inositol 1, 4, 5-trisphosphate receptor modulates cell death. The FASEB Journal: Official Publication of the Federation of American Societies for Experimental Biology, 14, 1375.
4. Brown, T.J., Crawford, S.E., Cornwall, M.L., Garcia, F., Shulman, S.T. & Rowley, A.H. (2001) CD8 T lymphocytes and macrophages infiltrate coronary artery aneurysms in acute Kawasaki disease. Journal of Infectious Diseases, 184, 940.
5. Cartegni, L., Chew, S.L. & Krainer, A.R. (2002) Listening to silence and understanding nonsense: exonic mutations that affect splicing. Nature Reviews Genetics, 3, 285.
6. Chamary, J.V., Parmley, J.L. & Hurst, L.D. (2006) Hearing silence: non-neutral evolution at synonymous sites in mammals. Nature Reviews Genetics, 7, 98.
7. Chi, H., Huang, F.Y., Chen, M.R., Chiu, N.C., Lee, H.C., Lin, S.P. et al. (2010) ITPKC gene SNP rs28493229 and Kawasaki disease in Taiwanese children. Human Molecular Genetics, 19, 1147.
8. Cook, D.H., Antia, A., Attie, F., Gersony, W.M., Kamiya, T., Kato, H. et al. (1989) Results from an international survey of Kawasaki disease in 1979-82. Canadian Journal of Cardiology, 5, 389.
9. Danesh, J., Wheeler, J.G., Hirschfield, G.M., Eda, S., Eiriksdottir, G., Rumley, A. et al. (2004) C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease. The New England Journal of Medicine, 350, 1387.
10. Dergun, M., Kao, A., Hauger, S.B., Newburger, J.W. & Burns, J.C. (2005) Familial occurrence of Kawasaki syndrome in North America. Archives of Pediatrics & Adolescent Medicine, 159, 876.
11. Fujita, Y., Nakamura, Y., Sakata, K., Hara, N., Kobayashi, M., Nagai, M. et al. (1989) Kawasaki disease in families. Pediatrics, 84, 666.
12. Furuno, K., Takada, H., Yamamoto, K., Ikeda, K., Ohno, T., Khajoee, V. et al. (2007) Tissue inhibitor of metalloproteinase 2 and coronary artery lesions in Kawasaki disease. Journal of Pediatrics, 151, 155.
13. Hanson, C.J., Bootman, M.D. & Roderick, H.L. (2004) Cell signalling: IP3 receptors channel calcium into cell death. Current Biology, 14, R933.
14. Hill, A.V. (1998) The immunogenetics of human infectious diseases. Annual Review of Immunology, 16, 593.
15. Ikeda, K., Ihara, K., Yamaguchi, K., Muneuchi, J., Ohno, T., Mizuno, Y. et al. (2008) Genetic analysis of MMP gene polymorphisms in patients with Kawasaki disease. Pediatrics Research, 63, 182.
16. Imboden, J.B. & Pattison, G. (1987) Regulation of inositol 1, 4, 5-trisphosphate kinase activity after stimulation of human T cell antigen receptor. Journal of Clinical Investigation, 79, 1538.
17. Jin, H.S., Kim, H.B., Kim, B.S., Lee, J.K., Seo, E.J., Yoo, H.W. et al. (2007) The IL-10 (-627 A/C) promoter polymorphism may be associated with coronary aneurysms and low serum albumin in Korean children with Kawasaki disease. Pediatrics Research, 61, 584.
18. Kariyazono, H., Ohno, T., Khajoee, V., Ihara, K., Kusuhara, K., Kinukawa, N. et al. (2004) Association of vascular endothelial growth factor (VEGF) and VEGF receptor gene polymorphisms with coronary artery lesions of Kawasaki disease. Pediatrics Research, 56, 953.
19. Kim, J.J., Hong, S.J., Hong, Y.M., Kim, S., Kang, M.J., Kim, K.J. et al. (2008) Genetic variants in the HLA-G region are associated with Kawasaki disease. Human Immunology, 69, 867.
20. Lin, Y.J., Wan, L., Wu, J.Y., Sheu, J.J., Lin, C.W., Lan, Y.C. et al. (2009) HLA-E gene polymorphism associated with susceptibility to Kawasaki disease and formation of coronary artery aneurysms. Arthritis and Rheumatism, 60, 604.
21. 2+ signals into mitochondria. Journal of Biological Chemistry, 280, 40892.
22. Nishimura, S., Zaitsu, M., Hara, M., Yokota, G., Watanabe, M., Ueda, Y. et al. (2003) A polymorphism in the promoter of the CD14 gene (CD14/-159) is associated with the development of coronary artery lesions in patients with Kawasaki disease. Journal of Pediatrics, 143, 357.
23. Oishi, T., Iida, A., Otsubo, S., Kamatani, Y., Usami, M., Takei, T. et al. (2008) A functional SNP in the NKX2.5-binding site of ITPR3 promoter is associated with susceptibility to systemic lupus erythematosus in Japanese population. Journal of Human Genetics, 53, 151.
24. Onouchi, Y., Gunji, T., Burns, J.C., Shimizu, C., Newburger, J.W., Yashiro, M. et al. (2008) ITPKC functional polymorphism associated with Kawasaki disease susceptibility and formation of coronary artery aneurysms. Nature Genetics, 40, 35.
25. Pagani, F. & Baralle, F.E. (2004) Genomic variants in exons and introns: identifying the splicing spoilers. Nature Reviews Genetics, 5, 389.
26. Pan, W.H., Fann, C.S., Wu, J.Y., Hung, Y.T., Ho, M.S., Tai, T.H. et al. (2006) Han Chinese cell and genome bank in Taiwan: purpose, design and ethical considerations. Human Heredity, 61, 27.
27. Patterson, R.L., Boehning, D. & Snyder, S.H. (2004) Inositol 1, 4, 5-trisphosphate receptors as signal integrators. Annual Review of Biochemistry, 73, 437.
28. Qu, H.Q., Marchand, L., Szymborski, A., Grabs, R. & Polychronakos, C. (2008) The association between type 1 diabetes and the ITPR3 gene polymorphism due to linkage disequilibrium with HLA class II. Genes and Immunity, 9, 264.
29. Quasney, M.W., Bronstein, D.E., Cantor, R.M., Zhang, Q., Stroupe, C., Shike, H. et al. (2001) Increased frequency of alleles associated with elevated tumor necrosis factor-alpha levels in children with Kawasaki disease. Pediatrics Research, 49, 686.
30. Ridker, P.M., Rifai, N., Clearfield, M., Downs, J.R., Weis, S.E., Miles, J.S. et al. (2001) Measurement of C-reactive protein for the targeting of statin therapy in the primary prevention of acute coronary events. The New England Journal of Medicine, 344, 1959.
31. Roach, J.C., Deutsch, K., Li, S., Siegel, A.F., Bekris, L.M., Einhaus, D.C. et al. (2006) Genetic mapping at 3-kilobase resolution reveals inositol 1, 4, 5-triphosphate receptor 3 as a risk factor for type 1 diabetes in Sweden. American Journal of Human Genetetics, 79, 614.
32. Rowley, A.H., Baker, S.C., Orenstein, J.M. & Shulman, S.T. (2008) Searching for the cause of Kawasaki disease--cytoplasmic inclusion bodies provide new insight. Nature Reviews Microbiology, 6, 394.
33. Singh, N., Agrawal, S. & Rastogi, A.K. (1997) Infectious diseases and immunity: special reference to major histocompatibility complex. Emerging Infectious Diseases, 3, 41.
34. Taniuchi, S., Masuda, M., Teraguchi, M., Ikemoto, Y., Komiyama, Y., Takahashi, H. et al. (2005) Polymorphism of Fc gamma RIIa may affect the efficacy of gamma-globulin therapy in Kawasaki disease. Journal of Clinical Immunology, 25, 309.
35. Taubert, K.A. & Shulman, S.T. (1999) Kawasaki disease. American Family Physician, 59, 3093.
36. Uehara, R., Yashiro, M., Nakamura, Y. & Yanagawa, H. (2003) Kawasaki disease in parents and children. Acta Paediatrica, 92, 694.
37. Visser, M., Bouter, L.M., McQuillan, G.M., Wener, M.H. & Harris, T.B. (1999) Elevated C-reactive protein levels in overweight and obese adults. Journal of the American Medical Association, 282, 2131.